Show notes
Welcome to Season 2 of AMC Clinical Deep Dive!
Probiotics are a high-yield OSCE topic, from preventing antibiotic-associated diarrhoea (AAD) to reducing infant eczema risk by 80%. This episode explores NHMRC Level 1 evidence for Lactobacillus rhamnosus GG and Saccharomyces boulardii. We break down the optimal dose (5–40 billion CFU/day) and the critical safety red flag: always avoid probiotics in immunocompromised or critically ill patients due to sepsis risks. Master strain-specific prescribing and the "sprinkle" technique for infants to deliver the evidence-based management plan examiners…
Website: podcasters.spotify.com

